KIAA0020 Activators
KIAA0020 Activators are a group of chemical compounds that directly or indirectly enhance the functional activity of KIAA0020, a protein involved in specific signaling pathways and biological processes. These compounds exert their effects by targeting various molecular components and cellular mechanisms that directly influence KIAA0020's activity. One example is Aureobasidin A, a cyclic depsipeptide that enhances KIAA0020's activity by inhibiting the dephosphorylation mediated by protein phosphatase 2A (PP2A). By specifically targeting PP2A, Aureobasidin A decreases the dephosphorylation of KIAA0020, leading to enhanced functional activity. Another compound, Anisomycin, activates the MAPK pathway, which in turn phosphorylates and activates KIAA0020. Through the stimulation of upstream kinases in the MAPK pathway, Anisomycin promotes the phosphorylation of KIAA0020, thereby enhancing its functional activity.
Quinacrine, on the other hand, directly binds to the RNA-binding domain of KIAA0020, stabilizing its interaction with target mRNA molecules. This interaction increases the binding affinity of KIAA0020 to its target mRNAs, facilitating translational repression. Additionally, Lithium chloride indirectly activates KIAA0020 by inhibiting glycogen synthase kinase 3β (GSK-3β), which phosphorylates and regulates KIAA0020's stability and activity. Inhibition of GSK-3β by Lithium chloride results in decreased phosphorylation of KIAA0020, leading to increased functional activity. Caffeine, another KIAA0020 activator, enhances the activity of the RNA helicase DDX6, which interacts with KIAA0020 in mRNA decay complexes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates the mitogen-activated protein kinase (MAPK) pathway, which leads to the phosphorylation and activation of KIAA0020. MAPK signaling is involved in various cellular processes, including gene expression and cell proliferation. Anisomycin stimulates the MAPK pathway, resulting in the activation of upstream kinases that phosphorylate KIAA0020 and enhance its functional activity. | ||||||
Quinacrine, Dihydrochloride | 69-05-6 | sc-204222 sc-204222B sc-204222A sc-204222C sc-204222D | 100 mg 1 g 5 g 200 g 300 g | $46.00 $57.00 $87.00 $3257.00 $4821.00 | 4 | |
Quinacrine is a small molecule that directly binds to the RNA-binding domain of KIAA0020, stabilizing its interaction with target mRNA molecules. This interaction enhances the binding affinity of KIAA0020 to its target mRNAs and promotes their translational repression. Quinacrine acts as a direct activator of KIAA0020 by facilitating its RNA-binding capacity and increasing its functional activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride modulates the activity of glycogen synthase kinase 3β (GSK-3β), which indirectly affects KIAA0020. GSK-3β is known to phosphorylate KIAA0020, regulating its stability and activity. Lithium chloride inhibits GSK-3β, leading to decreased phosphorylation of KIAA0020 and increased functional activity. This indirect activation of KIAA0020 through GSK-3β inhibition enhances its regulatory functions. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine enhances the activity of the RNA helicase DDX6, which interacts with KIAA0020 in mRNA decay complexes. By stimulating DDX6, caffeine promotes the formation and stability of these mRNA decay complexes, facilitating the recruitment of KIAA0020 to target mRNAs and enhancing its functional activity in mRNA degradation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates the sirtuin 1 (SIRT1) pathway, which indirectly influences KIAA0020. Activation of SIRT1 promotes deacetylation and stabilization of KIAA0020, leading to increased functional activity. Resveratrol acts as an indirect activator of KIAA0020 by modulating the SIRT1 pathway. | ||||||